comparemela.com

Latest Breaking News On - Infection at two community - Page 1 : comparemela.com

LumiraDx Announces the Intended Use for its FDA EUA Authorized High Sensitivity COVID-19 Antigen Test has been Expanded to Include Testing of Asymptomatic Individuals

/PRNewswire/ Today, LumiraDx (Nasdaq: LMDX) a next-generation point of care (POC) diagnostics company announced that the intended use for its Food and Drug.

United kingdomUnited statesPima countyCity ofNigel lindnerColleen mcmillenAmerj clinPharmacy incTesting at two university campusesDrug administrationMelinda gates foundationNational health serviceInfection at two communityExchange commissionUniversity of washingtonGlobal health

LumiraDx Announces the Intended Use for its FDA EUA Authorized High Sensitivity COVID-19 Antigen Test has been Expanded to Include Testing of Asymptomatic Individuals

- Microfluidic immunofluorescence assay authorized for screening asymptomatic individuals using a single test with results available in 12 minutes - The test performance for viral antigen

United kingdomUnited statesPima countyCity ofNigel lindnerColleen mcmillenAmerj clinPharmacy incTesting at two university campusesDrug administrationMelinda gates foundationNational health serviceInfection at two communityExchange commissionUniversity of washingtonDepartments of global health

vimarsana © 2020. All Rights Reserved.